MAD2L2 and lung carcinoma: We investigated the associations between SNPs in the MAD2L2, XPC, XRCC3, BRCA2, RAD52, NFKB1, NFKBIA, TNFRSF1A, or FASN genes and prognosis in patients with lung cancer who received platinum-based chemotherapy.